UKCAT and medical student selection in the UK – what has changed since 2006?

por Greatrix, Rachel, Dowell, Jonathan
Publicado 2020

Modern management of malignant pleural mesothelioma

por Patel, Shivani C, Dowell, Jonathan E
Publicado 2016

Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date

por Levin, Pavel A, Dowell, Jonathan E
Publicado 2017

Beyond ‘health and safety’ – the challenges facing students asked to work outside of their comfort, qualification level or expertise on medical elective placement

por Wiskin, Connie, Dowell, Jonathan, Hale, Catherine
Publicado 2018

Widening access to UK medical education for under-represented socioeconomic groups: modelling the impact of the UKCAT in the 2009 cohort

por Tiffin, Paul A, Dowell, Jonathan S, McLachlan, John C
Publicado 2012

The UKCAT-12 study: educational attainment, aptitude test performance, demographic and socio-economic contextual factors as predictors of first year outcome in a cross-sectional co...

por McManus, I C, Dewberry, Chris, Nicholson, Sandra, Dowell, Jonathan S
Publicado 2013

Predictive validity of the UK clinical aptitude test in the final years of medical school: a prospective cohort study

por Husbands, Adrian, Mathieson, Alistair, Dowell, Jonathan, Cleland, Jennifer, MacKenzie, Rhoda
Publicado 2014

Construct-level predictive validity of educational attainment and intellectual aptitude tests in medical student selection: meta-regression of six UK longitudinal studies

por McManus, IC, Dewberry, Chris, Nicholson, Sandra, Dowell, Jonathan S, Woolf, Katherine, Potts, Henry WW
Publicado 2013

A randomized, phase 2 study of deoxyuridine triphosphatase inhibitor, TAS-114, in combination with S-1 versus S-1 alone in patients with advanced non-small-cell lung cancer

por Yamamoto, Nobuyuki, Hayashi, Hidetoshi, Planchard, David, Morán, Teresa, Gregorc, Vanesa, Dowell, Jonathan, Sakai, Hiroshi, Yoh, Kiyotaka, Nishio, Makoto, Cortot, Alexis B., Benhadji, Karim A., Soni, Nital, Huang, Jinhong, Makris, Lukas, Cedres, Susana
Publicado 2020

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors

por Mundra, Vatsala, Yang, Yuqiu, von Itzstein, Mitchell S., Fattah, Farjana, Gonugunta, Amrit S., Hannan, Raquibul, Pop, Laurentiu M., Zhang, Yuanyuan, Wang, Yiqing, Sheffield, Thomas, Xie, Yang, Dowell, Jonathan E., Homsi, Jade, Rashdan, Sawsan, Park, Jason, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E.
Publicado 2023

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial

por Kim, Edward S., Velcheti, Vamsidhar, Mekhail, Tarek, Yun, Cindy, Shagan, Sarah M., Hu, Sylvia, Chae, Young Kwang, Leal, Ticiana A., Dowell, Jonathan E., Tsai, Michaela L., Dakhil, Christopher S. R., Stella, Philip, Jin, Yanling, Shames, David S., Schleifman, Erica, Fabrizio, David A., Phan, See, Socinski, Mark A.
Publicado 2022

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis

por Gerber, David E., Beg, M. Shaalan, Fattah, Farjana, Frankel, Arthur E., Fatunde, Oluwatomilade, Arriaga, Yull, Dowell, Jonathan E., Bisen, Ajit, Leff, Richard D., Meek, Claudia C., Putnam, William C., Kallem, Raja Reddy, Subramaniyan, Indhumathy, Dong, Ying, Bolluyt, Joyce, Sarode, Venetia, Luo, Xin, Xie, Yang, Schwartz, Brian, Boothman, David A.
Publicado 2018

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

por von Itzstein, Mitchell S., Gonugunta, Amrit S., Sheffield, Thomas, Homsi, Jade, Dowell, Jonathan E., Koh, Andrew Y., Raj, Prithvi, Fattah, Farjana, Wang, Yiqing, Basava, Vijay S., Khan, Shaheen, Park, Jason Y., Popat, Vinita, Saltarski, Jessica M., Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E.
Publicado 2022

Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway

por Zhang, Wei, Bhagwath, Ankur S., Ramzan, Zeeshan, Williams, Taylor A., Subramaniyan, Indhumathy, Edpuganti, Vindhya, Kallem, Raja Reddy, Dunbar, Kerry B., Ding, Peiguo, Gong, Ke, Geurkink, Samuel A., Beg, Muhammad S., Kim, James, Zhang, Qiuyang, Habib, Amyn A., Choi, Sung-Hee, Lapsiwala, Ritu, Bhagwath, Gayathri, Dowell, Jonathan E., Melton, Shelby D., Jie, Chunfa, Putnam, William C., Pham, Thai H., Wang, David H.
Publicado 2021